Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Blood Advances|September 8, 2018
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamideLaura K Schoch, Kenneth R Cooke, Nina D Wagner-Johnston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2020
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort StudySuman Paul, Marianna Zahurak, Leo Luznik, et al.
Blood Advances|December 18, 2024
Improved overall survival with checkpoint inhibition and allogeneic transplantation in relapsed Hodgkin lymphomaNadeem Tabbara, Marianna Zahurak, Cole H Sterling, et al.
Cancers|July 2, 2021
Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (<sup>111</sup>In)/Yttrium 90 (<sup>90</sup>Y) Ibritumomab Tiuxetan (Zevalin<sup>®</sup>) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose LevelsRichard L Wahl, Eric C Frey, Heather A Jacene, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2019
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic LeukemiaSuman Paul, Hua-Ling Tsai, Patrick Lowery, et al.
Transplantation|October 25, 2006
Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative disease after solid organ transplantationMarion Subklewe, René Marquis, Sylvain Choquet, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanningYvette L Kasamon, Richard L Wahl, Harvey A Ziessman, et al.
Blood|February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphomaYvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
Leukemia & Lymphoma|July 16, 2011
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomasDouglas E Gladstone, Javier Bolaños-Meade, Carol Ann Huff, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2013
Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphomaJennifer A Kanakry, Yvette L Kasamon, Christopher D Gocke, et al.
Pageof 8